Ultram Overdose Symptoms
The symptoms of an Ultram overdose can include a slow or irregular heartbeat, slow breathing,
periods of fainting or a seizure. If patients taking Ultram experience any of these symptoms,
they should treat the experience as an overdose and are urged to contact authorities instantly. If
the patient is in the U.S., they should call the National Poison Hotline at 1-800-222-1222. If you
have issues in Canada, call the poison control center in the province in which you live. Residents
of Australia, should make a free call to the Australian Poisons Information Centre at 13 11 12.
People in Great Britain, need to phone NHS Direct toll-free by dialing 111, or 999 if it’s urgent.
Ultram Side Effects
The U. S. Food and Drug Administration (FDA) uses a one to five scale to judge the
addictiveness of a drug, with one indicating the most addictive drug and five being the least
addictive. Based on this scale, the FDA has decided that Ultram ranks as a four, which means
that this drug is not very addictive. However, there are some possibilities of addiction when
To avoid addiction, the most important fact while taking Ultram is to do so while under the
supervision of a physician who can watch for signs of addiction. A legal prescription gives you
access to a physician, and in this situation a patient may be able to take Ultram for many years
without habit-forming consequences.
If patients stop taking Ultram all at once, they may experience symptoms of withdrawal.
These symptoms may include sneezing, sweating, tremors, aggressiveness, heart palpitations,
nightmares, headaches, severe mood swings, insomnia, depression, anxiety and anguish. To
avoid these symptoms, Ultram must be reduced gradually. These signs of withdrawal are often
experienced 12 to 20 hours after the last dose of Ultram is taken.
Any person who is prescribed Ultram should tell his or her physician any medical history that
involves liver or kidney disease; any disorders of the brain, such as seizures, tumors or head
injury; breathing problems, such as sleep apnea, asthma or chronic obstructive pulmonary
disease (COPD); intestinal problems, such as constipation, stomach blockage or diarrhea caused
by an infection; an enlarged prostate that creates urination issues; mood disorders, such as
depression, drug or alcohol abuse or suicidal tendencies.
Patients should refrain from using alcoholic beverages while taking Ultram. Also, people using
Ultram should inform their dentist or doctor before any surgery.
Occasionally, a patient taking Ultram may experience side effects such as dizziness, sweating,
constipation, skin rash or itching, or vomiting. For the most part, these side effects fade with
ongoing usage of Ultram by the patient. Eating a high fiber diet while taking Ultram can reduce
problems with constipation.
To reduce feelings of dizziness, any patient who experiences this side effect while taking Ultram
should stand up slowly.
Immediate medical attention is necessary if the patient taking Ultram experiences confusion,
slow breathing or difficulty swallowing, difficulty waking up or extreme sleepiness, severe
stomach pain, agitation, a seizure, fainting, hallucinations or difficulty urinating.
An extreme side effect of taking Ultram is a problem known as serotonin syndrome. Symptoms
of this issue include a fever, extreme dizziness, rapid heartbeat, twitching muscles and loss of
coordination, along with confusion, hallucinations and agitation. Serotonin syndrome requires
immediate medical attention, because it can cause death if left untreated.
If a dose as high as 700 milligrams is taken orally, or an intravenous dose of 300 milligrams is
given to a patient, a seizure can result. The seizure can take the form of a tonic-clonic seizure,
also known as a grand mal seizure, that involves all parts of the brain. Patients most at risk for
seizures when taking Ultram tend to be people between ages 25 to 54 who have received more
than four Ultram prescriptions. They also tend to be people who have experienced a stroke or
head injury, or who have a problem with alcohol abuse.
Some members of the medical establishment argue that the opiate-like qualities of Ultram makes
it an at risk drug, because it can numb the personality of a patient, as well as reduce brain
functions such as remembering activities, thinking and understanding.
If Ultram is used along with other medications, and then patients suddenly stop taking Ultram,
they can have withdrawal symptoms on the order of uncontrollable muscle contractions or
tremors. Sometimes patients experience anxiety, a buzzing feeling or feelings of an electric
shock. Another problem that is possible with Ultram use is a sexual dysfunction, such as delayed
Researchers in Australia have discovered a direct link between Ultram and the onset of seizures
in people who were already at risk for seizures. If Ultram is taken with SSRI drugs, the
combination creates serotonin poisoning of the brain, a fatal condition. Ultram used with MAOI
drugs cancels out any effects of the antidepressant drugs.
In a 2001 study, patients were given Ultram along with acetaminophen (Tylenol). The results
of the study showed that 17 percent of the study group felt sleepiness, nausea occurred for
17 percent, 15 percent experienced dizziness, constipation was a problem for 11 percent, 11
percent had a headache, seven percent of patients had vomiting issues, six percent had diarrhea,
dry mouth was a problem for five percent, five percent experienced fatigue, five percent had
indigestion, and less than one percent suffered a seizure.
In a separate study, researchers measured the occurrence of side effects when Ultram was
used for up to seven days, up to 30 days and up to 90 days. The study found that the more
continuously the drug was used over a given period of time, the greater the chance for side
effects. As an example, in patients who used Ultram for up to seven days, dizziness was noticed
by 26 percent. The number of patients experiencing dizziness rose to 31 percent when Ultram
was used up to 30 days, and the number rose to 33 percent in patients taking the drug for as
long as 90 days. Within the same time frames, patients had nausea 24 percent, 34 percent and
40 percent respectively; constipation was felt by 24 percent, 38 percent and 46 percent of
patients; headaches occurred in 18 percent, 26 percent and 32 percent of patients; 16 percent, 23
percent and 25 percent of patients reported drowsiness; nine percent, 13 percent and 17 percent
experienced vomiting; itchy skin was a problem for eight percent, 10 percent and 11 percent;
seven percent, 11 percent and 14 percent had anxiety; weakness was a side effect for six percent,
11 percent and 12 percent of patients; sweating was felt by six percent, seven percent and nine
percent; indigestion occurred for five percent, nine percent and 13 percent; dry mouth was a
problem for five percent, nine percent and 10 percent of patients; and diarrhea was an issue for
five percent, six percent and 10 percent of study patients.
Although doctors in the Philippines prescribe Ultram to reduce labor pains, the general
recommendation is that pregnant women should avoid taking this drug, except where advantages
of taking Ultram can outweigh any side effect issues for the baby. Studies indicate that Ultram is
present in the breast milk of a mother.
Sometimes the first dose of Ultram triggers anaphylactoid reactions. Allergic reaction symptoms
include swelling below the skin, hives, severe itching, bronchial tube spasms, and skin layer
detachment in a toxic epidermal necrolysis known as Stevens-Johnson syndrome. If a patient has
had a previous history of allergic reactions to taking codeine, this can indicate a risk when taking
Ultram, and this drug should not be prescribed.